Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Breakthrough in Specimen Banking Supports High-tech Research

Published: Saturday, September 29, 2012
Last Updated: Friday, October 05, 2012
Bookmark and Share
NovoPath, Inc. announces NovoBioBank, which operates as either a stand-alone or integrated system, seamlessly interfacing with Laboratory Information Systems and Clinical Research Information Systems.

A well-administered biobank is critical for conducting high-quality sophisticated biological research, and NovoBioBank provides all necessary tools. This fully customizable intuitive software solution, based on user-designed specs, supports effortless, scalable collaboration between multiple sites. NovoBioBank is a robust, flexible module that enables collection of pertinent specimen data, extensive search parameters and on-the-spot information – including order status, shipping, billing and maintenance reports.

NovoBioBank supports the capture, standardization and organization of wide-ranging relevant data – both patient/donor and biospecimen oriented – providing secure access to well-annotated biospecimens, while maintaining confirmed chain of custody. Data is managed and tracked through all phases of the complete biospecimen life-cycle – from informed consent, through annotation, collection, processing, QA, inventory/archival control, distribution fulfillment, and finally, to disposal. Full search capacity of operator-defined annotation and query criteria cover all data parameters from patient/donor demographics through to specimen molecular analysis – and everything in between.

Tim Marshall, NovoPath’s Vice President of Strategic Account Development, stated, “Today, biospecimens are being tapped to support research geared toward understanding the mechanisms of disease, identifying novel drug targets, developing clinically relevant biomarkers and an expansive range of cutting-edge research. NovoBioBank now stands ready to help researchers harness the true power and value in their biobank, fueling contemporary investigation – from basic research to clinical trials – through the better management of well-characterized biospecimens.” 


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!